United States · FDA National Drug Code directory
UPTRAVI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66215-910_7c54a125-9778-41f5-b92c-181711e22e06
- Product NDC
- 66215-910
- Form
- TABLET, FILM COATED
- Composition / generic term
- Selexipag
- Labeler
- Actelion Pharmaceuticals US, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260523
- Source listing expiry
- 20271231
Source-listed ingredients
- SELEXIPAG — 100 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (66215-910-14) / 140 TABLET, FILM COATED in 1 BOTTLE · 66215-910-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →